ReShape Lifesciences Inc. (RSLS)

ReShape Lifesciences Revenue

ReShape Lifesciences had revenue of $1.24M in the quarter ending June 30, 2025, a decrease of -36.79%. This brings the company's revenue in the last twelve months to $6.45M, down -19.81% year-over-year. In the year 2024, ReShape Lifesciences had annual revenue of $8.01M, down -7.74%.

• Revenue (ttm): $6.45M
• Revenue Growth: -19.81%
• P/S Ratio: 0.20
• Revenue / Employee: $358,444
• Employees: 18
• Market Cap: 10.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.01M	-672.00K	-7.74%
Dec 31, 2023	8.68M	-2.56M	-22.79%
Dec 31, 2022	11.24M	-2.36M	-17.35%
Dec 31, 2021	13.60M	2.30M	20.36%
Dec 31, 2020	11.30M	-3.79M	-25.12%